Object's details: Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction

Provider:Akademicka Platforma Czasopism

Description

Title:
Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction
Creator:
Arkadiusz Staroń;
Karkos, Patrycja;
Kuśmierczyk, Katarzyna;
Gastoł, Bartłomiej;
Mikołap, Karolina;
Kras, Marta;
Jurga, Marta
Description:
In recent years, the popularity of drugs which were firstly introduced as treatment for diabetes type 2 has surged, because of their’s significant effect of managing the body weight especially for patients that suffer for diabetes type 2. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is a glucagon-like-peptide 1 receptor agonist. The aim of our study is to present reliable and up-to-date knowledge of effects that both drugs provide and their beneficial effects on health.
Object availability:
free access
Rights: https://creativecommons.org/licenses/by-nc-sa/4.0 ;
Prawa autorskie (c) 2024 Arkadiusz Staroń, Patrycja Karkos, Katarzyna Kuśmierczyk, Bartłomiej Gastoł, Karolina Mikołap, Marta Kras, Marta Jurga
Date:
2024.08.17
Type:
info:eu-repo/semantics/article;
info:eu-repo/semantics/publishedVersion
Source:
Quality in Sport; Tom 19 (2024); 53518;
Quality in Sport; Vol. 19 (2024); 53518;
2450-3118
Publisher:
University Center for Sports Research, Nicolaus Copernicus University, Torun, Poland
Subject:
ozempic, semaglutide, GLP-1, DM2, obesity;
weight reduction;
mounjaro;
tirzepatide;
diabetes mellitus 2;
diabetes
Identifier: https://apcz.umk.pl/QS/article/view/53518
Data provider:
Akademicka Platforma Czasopism

Similar objects

Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction

Date:2024.08.17

Type:text

Ozempic (semaglutide) - review of pharmacological properties, mechanism of action and clinical applications

Date:2024.07.10

Type:text

Tirzepatide – a new hope for type 2 diabetes mellitus and obesity management. A literature review.

Creator:Stawicka, Izabela | Orzołek, Izabela | Jarmołowicz, Jakub | Boczar, Agata | Dryja, Patryk

Date:2024.11.12

Type:text

Challenges in managing de novo diabetes in adults: A case report of a 47 year old male

Date:2025.05.05

Type:text

Osobowość pacjentek z cukrzycą typu 2

Creator:Kocemba, Iwona

Date:2014.03.06 | 2003

Type:image

New-onset diabetes mellitus type 2 treated with metformin - is it possible to slow the development of pancreatic cancer?- case report: New-onset DM2 and pancreatic cancer treated with metformin

Date:2024.09.18

Type:text

The influence of the ketogenic diet on the therapy of type 2 diabetes. A literature review

Date:2024.02.04

Type:text

The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications: The importance of stem cells in diabetology

Date:2025.01.14

Type:text

Federacja Bibliotek Cyfrowych

Object's details: Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction

Description

Similar objects